RAFAEL HOLDINGS, INC. Increase (Decrease) in Accrued Liabilities
RAFAEL HOLDINGS, INC. (RFL) reported Increase (Decrease) in Accrued Liabilities of -$412.00 thousand for the 9-month period ending 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-04-30 was $0.00, a 100.00% decline year-over-year.
- RAFAEL HOLDINGS, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-01-31 was -$415.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-10-31 was $3.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-07-31 was $450.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in accrued liabilities for fiscal 2025 was $913.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in accrued liabilities for fiscal 2019 was $649.00K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-11 | -$415.00K derived: sum of 2 quarters · filed 2026-06-11 | -$412.00K 10-Q · filed 2026-06-11 | $38.00K derived: sum of 4 quarters · filed 2026-06-11 |
| 2026-01-31 | -$415.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-16 | -$412.00K 10-Q · filed 2026-03-16 | $38.00K derived: sum of 3 quarters · filed 2026-03-16 | $189.00K derived: sum of 4 quarters · filed 2026-06-11 |
| 2025-10-31 | $3.00K 10-Q · filed 2025-12-12 | $453.00K derived: sum of 2 quarters · filed 2025-12-12 | $604.00K derived: sum of 3 quarters · filed 2026-06-11 | |
| 2025-07-31 | $450.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $601.00K derived: sum of 2 quarters · filed 2026-06-11 | $913.00K 10-K · filed 2025-10-29 | |
| 2025-04-30 | $151.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-11 | $463.00K 10-Q · filed 2026-06-11 | ||
| 2025-01-31 | $312.00K 10-Q · filed 2026-03-16 | |||
| 2019-07-31 | $231.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-10-04 | $649.00K 10-K · filed 2019-10-04 | ||
| 2019-04-30 | $418.00K 10-Q · filed 2019-06-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |